ScholarIQanswers from OpenAlex & ORCID
Sean Wharton
ResearcherPublications, citations & collaboration network
Sean Wharton is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Sean Wharton have?
ScholarIQindexed works
Sean Wharton has 156 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Sean Wharton have?
ScholarIQcitation count
Sean Wharton has 17,660 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Sean Wharton?
ScholarIQh-index
Sean Wharton has an h-index of 38 in OpenAlex.
What is the i10-index of Sean Wharton?
ScholarIQi10-index
Sean Wharton has an i10-index of 70 in OpenAlex.
What is the ORCID of Sean Wharton?
ScholarIQorcid
The ORCID for Sean Wharton is on the source record.
What is the OpenAlex record for Sean Wharton?
ScholarIQopenalex
The OpenAlex for Sean Wharton is on the source record.
What are the most-cited papers on Sean Wharton?
ScholarIQmost cited works
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John Wilding, Rachel L. Batterham, Salvatore Calanna, Melanie J. Davies, Luc F. Van Gaal, Ildiko Lingvay, Barbara McGowan, Julio Rosenstock, Marie Thi Dao Tran, Thomas A. Wadden, Sean Wharton, Koutaro Yokote, Niels Zeuthen, Robert F. Kushner
Obesity in adults: a clinical practice guideline
Sean Wharton, David C.W. Lau, Michael Vallis, Arya M. Sharma, Laurent Biertho, Denise Campbell‐Scherer, Kristi B. Adamo, Angela S. Alberga, Rhonda C. Bell, Normand G. Boulé, Elaine Boyling, Jennifer Brown, Betty Calam, Carol Clarke, Lindsay Crowshoe, Dennis DiValentino, Mary Forhan, Yoni Freedhoff, Michel Gagner, Stephen Glazer, C. G. Grand, Michael Green, Margaret Hahn, Raed Hawa, Rita Henderson, Dennis Hong, Pam Hung, Ian Janssen, Kristen Jacklin, Carlene Johnson Stoklossa, Amy Kemp, Sara Kirk, Jennifer L. Kuk, Marie‐France Langlois, Scott A. Lear, Ashley McInnes, David Macklin, Leen Naji, Priya Manjoo, Marie‐Philippe Morin, Kara Nerenberg, Ian Patton, Sue D. Pedersen, Leticia Pereira, Helena Piccinini‐Vallis, Megha Poddar, Paul Poirier, Denis Prud’homme, Ximena Ramos Salas, Christian F. Rueda‐Clausen, Shelly Russell‐Mayhew, Judy Shiau, Diana Sherifali, John L. Sievenpiper, Sanjeev Sockalingam, Valerie H. Taylor, Ellen L. Toth, Laurie Twells, Richard Tytus, Shahebina Walji, Leah Walker, Sonja Wicklum
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The <scp>STEP</scp> 1 trial extension
John Wilding, Rachel L. Batterham, Melanie J. Davies, Luc F. Van Gaal, Kristian Kandler, Katerina Konakli, Ildiko Lingvay, Barbara McGowan, Tuğçe Kalaycı Oral, Julio Rosenstock, Thomas A. Wadden, Sean Wharton, Koutaro Yokote, Robert F. Kushner, STEP 1 Study Group
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
W. Timothy Garvey, Rachel L. Batterham, Meena Bhatta, Silvio Buscemi, Louise Christensen, Juan P. Frías, Esteban Jódar, Kristian Kandler, Georgia Rigas, Thomas A. Wadden, Sean Wharton, the STEP 5 Study Group
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Patrick M. O’Neil, Andreas L. Birkenfeld, Barbara McGowan, Ofri Mosenzon, Sue D. Pedersen, Sean Wharton, Charlotte Giwercman Carson, Cecilie H. Jepsen, Maria Kabisch, John Wilding